Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India
· Delayed Price · Currency is INR 2,117.60
-6.80 (-0.32%)
At close: Mar 9, 2026
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 597.59 billion as of March 9, 2026. Its market cap has increased by 50.06% in one year.
Market Cap
597.59B
Enterprise Value
582.93B
Revenue
165.10B
Ranking
n/a
PE Ratio
56.11
Stock Price
2,117.60
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 597.59B, an increase of 51,895.72%. That is a compound annual growth rate of 28.73%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 551.19B |
| Alkem Laboratories | 661.19B |
| Aurobindo Pharma | 715.49B |
| Mankind Pharma | 902.80B |
| Zydus Lifesciences | 914.52B |
| Ipca Laboratories | 381.22B |
| Ajanta Pharma | 373.66B |
| Cipla | 1,067.24B |